Özcan Met

15PUBLICATIONS
116CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 14, 2025
ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionality.

Annina Kurzay, Sara Fresnillo Saló, Anne Rahbech

|Sep 05, 2024
In vivo dendritic cell reprogramming for cancer immunotherapy.

Ervin Ascic, Fritiof Åkerström, Malavika Sreekumar Nair

|Jan 29, 2024
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma.

Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund

|Jul 07, 2023
Restoring tumor immunogenicity with dendritic cell reprogramming.

Olga Zimmermannova, Alexandra G Ferreira, Ervin Ascic

|Jun 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi

Pageof 3